These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 16164907)
21. The Vioxx debacle revisited. Good CB; Kelley CL Am J Med; 2005 Sep; 118(9):1055-6; author reply 1056-7. PubMed ID: 16164902 [No Abstract] [Full Text] [Related]
22. [Cardiovascular risk: a class effect of coxibs? How to manage patients taking Vioxx?]. Brune K; Zacher J MMW Fortschr Med; 2004 Oct; 146(42):10, 12. PubMed ID: 15536697 [No Abstract] [Full Text] [Related]
23. Thromboembolic cardiovascular risk among arthritis patients using cyclooxygenase-2-selective inhibitor or nonselective cyclooxygenase inhibitor nonsteroidal anti-inflammatory drugs. Spalding WM; Reeves MJ; Whelton A Am J Ther; 2007; 14(1):3-12. PubMed ID: 17303969 [TBL] [Abstract][Full Text] [Related]
24. Rofecoxib, Merck, and the FDA. Wolfe MM N Engl J Med; 2004 Dec; 351(27):2875-8; author reply 2875-8. PubMed ID: 15625749 [No Abstract] [Full Text] [Related]
25. COX-2 inhibitor use after Vioxx: careful balance or end of the rope? Fendrick AM Am J Manag Care; 2004 Nov; 10(11 Pt 1):740-1. PubMed ID: 15623263 [No Abstract] [Full Text] [Related]
27. The Vioxx debacle. Alpert JS Am J Med; 2005 Mar; 118(3):203-4. PubMed ID: 15745713 [No Abstract] [Full Text] [Related]
28. Does the pro-hypertensive effect of cyclooxygenase-2 inhibitors account for the increased risk in cardiovascular disease? Messerli FH; Sichrovsky T Am J Cardiol; 2005 Sep; 96(6):872-3. PubMed ID: 16169380 [No Abstract] [Full Text] [Related]
29. Does the dose make the poison? Harris RE Science; 2005 Apr; 308(5719):203. PubMed ID: 15821073 [No Abstract] [Full Text] [Related]
31. Adjusted indirect comparison of celecoxib versus rofecoxib on cardiovascular risk. Lee YH; Ji JD; Song GG Rheumatol Int; 2007 Mar; 27(5):477-82. PubMed ID: 17051359 [TBL] [Abstract][Full Text] [Related]
32. A tale of two coxibs. Hegmann T JAAPA; 2005 Mar; 18(3):14, 17. PubMed ID: 15789666 [No Abstract] [Full Text] [Related]
33. The Vioxx debacle. Fielder JH IEEE Eng Med Biol Mag; 2005; 24(2):106-9. PubMed ID: 15825852 [No Abstract] [Full Text] [Related]
34. [Cyclooxygenase inhibitors: a never ending story?]. Macrì R; Manfredi C G Ital Cardiol (Rome); 2006 Jul; 7(7):505-7. PubMed ID: 16977790 [No Abstract] [Full Text] [Related]
35. Merck cleared in personal injury case against Vioxx. Mayor S BMJ; 2005 Nov; 331(7525):1101. PubMed ID: 16282390 [No Abstract] [Full Text] [Related]
36. The safety of the perioperative administration of cyclooxygenase-2 inhibitors for post-surgical pain. Reuben SS Acta Anaesthesiol Scand; 2005 Mar; 49(3):424; author reply 425. PubMed ID: 15752415 [No Abstract] [Full Text] [Related]
37. The pain game. Wadman M Nature; 2007 Jul; 448(7152):400-1. PubMed ID: 17653159 [No Abstract] [Full Text] [Related]
38. [Pseudoporphyria and coxib]. Schmutz JL; Barbaud A; Trechot P Ann Dermatol Venereol; 2006 Feb; 133(2):213. PubMed ID: 16508618 [No Abstract] [Full Text] [Related]